Combinations of multiple, untested drugs should not be used at this time

Muscle and Nerve

Volumn 30, Issue 5, 2004, Pages 676-678

  Shefner, Jeremy M ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CYCLOPHOSPHAMIDE; GEMCITABINE; PACLITAXEL; RILUZOLE; XALIPRODEN; DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; DEATH; EPILEPSY; HUMAN; ONCOLOGY; OUTCOMES RESEARCH; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY; DRUG COMBINATION; PATHOPHYSIOLOGY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 16544372248     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20187     Document Type: Short Survey

References (11)

1. ALS CNTF Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996;46:1244-1249.
2. Andres P, Hedlund W, Finison L, Conlon T, Felmus M, Munsat T. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:937-941.
3. BDNF Study Group. A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999;52:1427-1433.
4. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330:585-591.
5. Beydoun A, Kutluay E. Conversion to monotherapy. Clincal trials in patients with refractory partial seizures. Neurology 2003;60:S13-S25.
6. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999;169:84-86.
7. Dantes M, McComas A. The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. Muscle Nerve 1991;7:416-421.
8. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation Science 1994;264:1772-1775.
9. Kwan P, Brodie M. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003;60:S2-S12.
10. Miller RG, Moore D, Young LA, Armon C, Barohn RJ, Bromberg MB, Bryan WW, Gelinas DF, Mendoza MC, Neville HE, Parry GJ, Petajan JH, Ravits JM, Ringel SP, Ross MA. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 1996;47:1383-1388.
11. Pioro EP. MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease. J Neurol Sci 1997;152:S49-S53.